Prof Ben Tran
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
465 Scholarly works
11 Projects
HIGHLIGHTS
2026
Journal article
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series
DOI: 10.1111/ajco.700832026
Journal article
XALience: A phase 3, open-label, multicenter, randomized study of xaluritamig plus abiraterone vs investigator’s choice in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer.
DOI: 10.1200/jco.2026.44.16_suppl.tps51442026
Journal article
IP13-16 ROBOTIC-ASSISTED RETROPERITONEAL LYMPH NODE DISSECTION FOR METASTATIC TESTICULAR MALIGNANCIES – A 9-YEAR COMPARATIVE ANALYSIS OF THE OUTCOMES AND LEARNING CURVE
DOI: 10.1097/01.ju.0001191348.53260.b7.162026
Journal article
Artificial Intelligence Chatbots as Information Sources on Testicular Cancer: Quality, Readability and Actionability
DOI: 10.3390/siuj70200272022
Research grants (ARC, NHMRC, MRFF)
Targeting Cold Tumours With Triple Therapy
2019
Research Grant
PRECEPT - PRostatE CancEr Prognosis and Treatment
2017
Research Grant
Combination of Radionuclide 177lu-Psma Therapy With Pembrolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
RECENT SCHOLARLY WORKS
2026
Journal article
Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro).
DOI: 10.1016/j.esmorw.2025.1006772026
Journal article
ctDNA monitoring of FGFR3-altered metastatic urothelial cancer treated with dabogratinib (formerly TYRA-300) in the SURF301 trial.
DOI: 10.1200/jco.2026.44.7_suppl.8092026
Conference Proceedings
P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-50 years with intermediate and poor-risk metastatic germ cell tumours (GCTs).
DOI: 10.1200/JCO.2026.44.7_suppl.TPS6232026
Journal article
Primary retroperitoneal lymph node dissection for clinical stage IIA/B metastatic seminoma: A multi-centre Australian experience.
DOI: 10.1200/jco.2026.44.7_suppl.6012026
Journal article
Treatment patterns and survival outcomes among lutetium 177–experienced patients with metastatic castration-resistant prostate cancer.
DOI: 10.1200/jco.2026.44.7_suppl.692026
Journal article
Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts
DOI: 10.1200/GO-25-00384
RECENT PROJECTS
2024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
2024
Research grants (ARC, NHMRC, MRFF)
P3BEP Trial - Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours - An Australian-Led, International Randomised Trial